Oral candidiasis secondary prevention

Oral candidiasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Oral candidiasis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Oral candidiasis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Oral candidiasis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Oral candidiasis secondary prevention
CDC on Oral candidiasis secondary prevention
Oral candidiasis secondary prevention in the news
Blogs on Oral candidiasis secondary prevention
Directions to Hospitals Treating Oral candidiasis
Risk calculators and risk factors for Oral candidiasis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]

Overview

Candida is usually a self limiting disease unless concurrent immunosuppression is present.

Secondary prevention

• Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
• In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.